- Investing Ideas
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Abbott India
Market Cap: ₹595.3b
Operates as a pharmaceutical company in India.
500488
₹28,013.60
7D
3.3%
1Y
-18.0%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹415.9b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,455.05
7D
0.8%
1Y
-21.9%
Sanofi India
Market Cap: ₹78.6b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,411.45
7D
0.02%
1Y
-42.6%